Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.34 |
| ▸ | HPGD | P15428 | 1/20 | 0.34 |
| ▸ | ATM | Q13315 | 1/20 | 0.34 |
| ▸ | MAPK1 | P28482 | 2/20 | 0.33 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.33 |
| ▸ | OGA | O60502 | 1/20 | 0.33 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.32 |
| ▸ | GBA2 | Q9HCG7 | 8/20 | 0.32 |
| ▸ | UGCG | Q16739 | 3/20 | 0.32 |
| ▸ | GAA | P10253 | 3/20 | 0.32 |
| ▸ | MGAM | O43451 | 2/20 | 0.32 |
| ▸ | SI | P14410 | 2/20 | 0.32 |
| ▸ | AGL | P35573 | 2/20 | 0.32 |
| ▸ | GBA1 | P04062 | 1/20 | 0.32 |
| ▸ | MEN1 | O00255 | 1/20 | 0.31 |
| ▸ | LMNA | P02545 | 1/20 | 0.31 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL16283147 | 0.95 | HPGD (0.31) | L3MBTL1HPGDATM | |
| SCHEMBL15025630 | 0.95 | HPGD (0.31) | L3MBTL1HPGDATM | |
| SCHEMBL16281911 | 0.89 | — | — | |
| SCHEMBL15032478 | 0.86 | ALDH1A1 (0.35) | KDM4EALDH1A1MEN1LMNAKMT2A | |
| SCHEMBL16307662 | 0.86 | ALDH1A1 (0.35) | KDM4EALDH1A1MEN1LMNAKMT2A | |
| SCHEMBL1144589 | 0.81 | CYP3A4 (0.32) | OGAGAAMGAM | |
| SCHEMBL15025256 | 0.79 | MEN1 (0.41) | L3MBTL1HPGDATMMAPK1KDM4E | |
| SCHEMBL15025628 | 0.79 | MEN1 (0.41) | L3MBTL1HPGDATMMAPK1KDM4E | |
| SCHEMBL16281908 | 0.76 | ALDH1A1 (0.35) | L3MBTL1HPGDATMMAPK1KDM4E | |
| SCHEMBL16307235 | 0.74 | ALDH1A1 (0.34) | KDM4EALDH1A1GAAMGAMLMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9321792-B2 | Hydrolysable silanes | DOW CORNING CORPORATION (US) | 2016-04-26 | — | — | US | disclosed |
| US-9321792-B2 | Hydrolysable silanes | DOW CORNING CORPORATION (US) | 2016-04-26 | — | — | US | disclosed |
| US-20140364627-A1 | Hydrolysable Silanes | DOW SILICONES CORPORATION | 2014-12-11 | — | — | US | disclosed |
| US-20140364627-A1 | Hydrolysable Silanes | DOW SILICONES CORPORATION | 2014-12-11 | — | — | US | disclosed |
| WO-2013083743-A1 | HYDROLYSABLE SILANES | DOW CORNING CORPORATION (US) | 2013-06-13 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20140364627-A1 | Hydrolysable Silanes | ESD, JMJD6, KDM5A | L3MBTL1 4374/4885HPGD 324/4885ATM 3332/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.